Multiple Sclerosis(MS) Presented by MANCHALU SRINIVAS 11408024 B.Tech Genetic Engineering VII Semester Also called as MS Scleorosis Disseminated Encephalomyelitis…
1. TY-PAN-0597(14) Date of preparation: July 2014 FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(14)…
1. eHealth: Improving patient engagement Gavin Giovannoni 2. •Serves on scientific advisory boards for Merck Serono, Biogen Idec and Vertex Pharmaceuticals; and on the…
U.S. RESEARCH AT A GLANCE JANUARY 13, 2010 RBC Insight is RBC's new global research destination on the web. To find out more, please contact your RBC Capital Markets'…
Biotechnology Industry in India • • • • • • Overview Scope Career Opportunities List of Top Companies Other Biotech Companies Recent Developments General Introduction…
1. Clinical implications: the potential of tailored MS treatment Gavin Giovannoni Blizard Institute of Cell and Molecular ScienceBarts and The London School of Medicine and…
1. Adapting to Business Communication Dr. Michael Edmondson 2. Communication skills are a work in progress 3. Have no fear of perfection - you'll never reach it. Salvador…
1. Kendall Square AssociationAnnual MeetingMarch 8, 2012Tim RoweFounder and CEOCambridge Innovation Center 2. At the end of the day,we all have the same priorities healthy…